Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Korean Journal of Radiology|January 19, 2017
T-Cell Non-Hodgkin Lymphomas: Spectrum of Disease and the Role of Imaging in the Management of Common SubtypesHye Sun Park, Lacey McIntosh, Marta Braschi-Amirfarzan, et al.
Radiology. Imaging Cancer|May 14, 2021
A Primer on RECIST 1.1 for Oncologic Imaging in Clinical Drug TrialsKathleen Ruchalski, Marta Braschi-Amirfarzan, Michael Douek, et al.
Korean Journal of Radiology|January 19, 2017
Radiology Consultation in the Era of Precision Oncology: A Review of Consultation Models and Services in the Tertiary SettingPamela J DiPiro, Katherine M Krajewski, Angela A Giardino, et al.
Korean Journal of Radiology|January 19, 2017
Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and ToxicitiesKatherine M Krajewski, Marta Braschi-Amirfarzan, Pamela J DiPiro, et al.
European Journal of Radiology Open|March 10, 2022
A radiologist's guide to novel anticancer therapies in the era of precision medicineAli Khader, Rozan Bokhari, Reza Hakimelahi, et al.
Clinical Imaging|April 26, 2020
A review of the imaging manifestations of immune check point inhibitor toxicitiesRichard Thomas, Bibin Sebastian, Tom George, et al.
European Journal of Radiology Open|August 1, 2022
Importance of tumor subtypes in cancer imagingAli Khader, Marta Braschi-Amirfarzan, Lacey J McIntosh, et al.
Abdominal Radiology (New York)|February 23, 2018
Value of hepatocellular phase imaging after intravenous gadoxetate disodium for assessing hepatic metastases from gastroenteropancreatic neuroendocrine tumors: comparison with other MRI pulse sequences and with extracellular agentSree Harsha Tirumani, Jyothi P Jagannathan, Marta Braschi-Amirfarzan, et al.
European Journal of Radiology Open|August 15, 2022
Imaging features of toxicities associated with immune checkpoint inhibitorsBabina Gosangi, Lacey McIntosh, Abhishek Keraliya, et al.
Abdominal Radiology (New York)|June 6, 2017
Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancerJooae Choe, Marta Braschi-Amirfarzan, Sree Harsha Tirumani, et al.
Pageof 4